# Strategic Moat Engine: Sample Case Artifact

**Case ID:** CASE-2025-006-MSFT-MARKET-URGENCY  
**Subject:** Microsoft (enterprise account manager)  
**Subject Type:** Individual  
**Case Created:** 2025-06-15  

---

## Case Context

Enterprise client (Microsoft) facing Q3 sales target pressure. Product team (market_intelligence_q2) is asked to support an "accelerated market assessment" to justify new product launch timing. The real question: should we release a new analytical tool to a customer before evidence is complete?

---

## Strategic Twin State Evolution

### Initial State (T0 - Case Intake)
```json
{
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "subjectType": "individual",
  "subjectName": "Sarah Chen, Enterprise Account Manager",
  "currentDecisionPressure": "high",
  "activeDecisionTheme": "product release timing vs. evidence maturity",
  "dominantContradictions": [
    "commercial_pressure_without_evidence",
    "authority_claim_without_artifact"
  ],
  "activeEvidenceGaps": [
    "customer_readiness_validation",
    "product_performance_baseline",
    "go_live_risk_assessment"
  ],
  "unresolvedCommitments": [],
  "repeatedPatterns": [],
  "currentInterventionReadiness": "signal_detected",
  "readinessReason": "Pattern recognized: urgency without adequate evidence",
  "stateConfidence": "medium",
  "confidenceReason": "Early intake, some context available"
}
```

### Memory Events Flow

**Event 1: Intake Signal (T0 + 2h)**
```json
{
  "eventId": "evt-001",
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "productCode": "market_intelligence_q2",
  "timestamp": "2025-06-15T09:30:00Z",
  "eventType": "intake_submitted",
  "authorityStateAtEvent": "review_in_progress",
  "readinessStatusAtEvent": "blocked",
  "contradictionKeys": [
    "commercial_pressure_without_evidence",
    "authority_claim_without_artifact"
  ],
  "evidenceGapKeys": [
    "customer_readiness_validation",
    "product_performance_baseline"
  ],
  "commitmentKeys": [],
  "consequenceKeys": []
}
```

**Event 2: Evidence Collection Initiated (T0 + 1d)**
```json
{
  "eventId": "evt-002",
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "productCode": "market_intelligence_q2",
  "timestamp": "2025-06-16T10:00:00Z",
  "eventType": "evidence_gap_identified",
  "evidenceGapKeys": [
    "customer_readiness_validation",
    "product_performance_baseline",
    "go_live_risk_assessment"
  ]
}
```

**Event 3: Contradiction Recurrence Detected (T0 + 3d)**
```json
{
  "eventId": "evt-003",
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "productCode": "reporting_output_layer",
  "timestamp": "2025-06-18T14:00:00Z",
  "eventType": "pattern_deteriorated",
  "contradictionKeys": [
    "urgency_without_evidence",
    "commitment_without_verification"
  ]
}
```

---

## Intervention Calibration Path

### First Calibration (T0 + 4h)
```json
{
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "calibratedAt": "2025-06-15T13:30:00Z",
  "calibratingProductCode": "market_intelligence_q2",
  "recommendedLevel": "evidence_limited_review",
  "reason": "Pattern recognized (urgency without evidence), partial data available; structured review of current evidence needed before escalation",
  "reasoning": {
    "evidenceState": "Partial evidence available with significant gaps; adequate for structured review",
    "patternRisk": "Pattern emerged 2–3 times; moderate recurrence risk",
    "readinessLevel": "Current readiness: signal_detected. Reason: Early intake signals pattern but insufficient for decision",
    "consequenceRisk": "high",
    "timelinessFactors": "Timeline constraint: Q3 sales target closing; Budget constraint: pre-committed resources"
  },
  "evidenceNeeded": [
    "customer_readiness_validation",
    "product_performance_baseline",
    "go_live_risk_assessment"
  ],
  "estimatedTimeToEvidence": "2–4 weeks for individual-focused evidence collection",
  "unsuitableInterventions": [
    "free_signal",
    "blocked_until_evidence"
  ],
  "unsuitableReasons": [
    "Advisory insufficient for recurring issue",
    "Decision needed, evidence sufficient"
  ],
  "riskIfDelayed": "Moderate deferral cost; window of 4–8 weeks available",
  "recommendedFollowupAt": "2025-06-29",
  "boundaryNotice": "Evidence is incomplete; analysis informs decision but does not guarantee outcome; Consequence risk is elevated; verification governance required post-decision"
}
```

### Second Calibration After Evidence Collection (T0 + 8d)
```json
{
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "calibratedAt": "2025-06-23T11:00:00Z",
  "calibratingProductCode": "reporting_output_layer",
  "recommendedLevel": "reporting_output",
  "reason": "Sufficient evidence (65% available) and clear decision need; structured decision support appropriate. Evidence gaps identified for post-launch verification.",
  "reasoning": {
    "evidenceState": "Substantial evidence available; some gaps remain manageable",
    "patternRisk": "Pattern recurred 3 times; high systemic risk; root cause requires investigation",
    "readinessLevel": "Current readiness: evidence_needed. Reason: Evidence collection in progress, 65% complete",
    "consequenceRisk": "high",
    "timelinessFactors": "Timeline constraint: Q3 sales target closing (14 days)"
  },
  "evidenceNeeded": [
    "go_live_risk_assessment (in-progress)",
    "post-launch monitoring protocol"
  ],
  "estimatedTimeToEvidence": "1 week for completion of go_live_risk_assessment",
  "unsuitableInterventions": [
    "board_facing_draft",
    "blocked_until_evidence"
  ],
  "unsuitableReasons": [
    "Operational decision, board escalation not required",
    "Decision cannot wait for 100% evidence; deferral window closing"
  ],
  "riskIfDelayed": "High deferral cost; decision cannot wait indefinitely",
  "recommendedFollowupAt": "2025-06-30",
  "boundaryNotice": "Evidence is incomplete; analysis informs decision but does not guarantee outcome; Consequence risk is elevated; verification governance required post-decision; Pattern has recurred; investigate root cause to prevent future recurrence"
}
```

---

## Commitment Tracking

**Commitment 1: Evidence Collection**
```json
{
  "commitmentId": "commit-001",
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "commitment": "Complete customer readiness assessment by June 22",
  "committedBy": "Sarah Chen",
  "committedAt": "2025-06-16T10:00:00Z",
  "verificationDueAt": "2025-06-22T17:00:00Z",
  "verificationStatus": "pending",
  "verificationOutcome": null
}
```

**Commitment 2: Post-Launch Governance**
```json
{
  "commitmentId": "commit-002",
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "commitment": "Establish weekly verification cycle for first 30 days post-launch",
  "committedBy": "Product governance team",
  "committedAt": "2025-06-23T11:00:00Z",
  "verificationDueAt": "2025-07-23T17:00:00Z",
  "verificationStatus": "accepted",
  "verificationOutcome": null
}
```

---

## Consequence Tracking

**Consequence 1: Release Impact**
```json
{
  "consequenceId": "cons-001",
  "caseId": "CASE-2025-006-MSFT-MARKET-URGENCY",
  "linkedCommitmentId": "commit-001",
  "linkedWarningId": "warn-override-without-governance",
  "consequence": "If launched without complete evidence, customer may encounter undocumented limitations",
  "riskLevel": "high",
  "verificationState": "not_due",
  "verificationDueAt": "2025-07-30T17:00:00Z"
}
```

---

## Authority Blocking Gates Status

**Gate 1: Authority Grant Firewall** ✓ PASS
- No false authority claims in case context
- Decision remains within evidence boundaries

**Gate 2: Evidence Ledger Validation** ✓ PASS
- Evidence sources documented: customer assessment (65%), product baseline (80%)
- Evidence gaps explicitly identified

**Gate 3: Report-As-Evidence Prevention** ✓ PASS
- Calibration recommendations are advice, not authority
- Report used to inform decision, not grant authority

**Gate 4: Authority Restoration Firewall** ✓ PASS
- No authority restoration attempted
- Case remains in review_in_progress state

**Gate 5: Commercial Route Gating** ✓ PASS
- Commercial pressure acknowledged and bounded
- Decision deferred until evidence reaches acceptable threshold

**Gate 6: Forbidden Claims Guard** ✓ PASS
- No claims of certainty made
- All outputs include boundary notices and evidence limitations

**Gate 7: Surface Claim Authority** ✓ PASS
- Evidence gaps visible in all communications
- Public claim permission: BLOCKED (insufficient evidence)
- Current authority state: review_in_progress

---

## Key Lesson: Strategic Moat Value

**Competitors would do:** "We recommend immediate launch; urgency requires speed"  
**Our system does:** "Urgency is real, evidence is 65% ready, decision possible with post-launch verification governance"

The moat: we don't pretend evidence is complete. We calibrate the intervention to the real state (high pressure, partial evidence, repeating pattern) and recommend what's actually safe here—structured decision support with mandatory follow-up governance.

Result: Customer got the decision they needed, with clear boundaries about what will require ongoing verification.
